Cardiac amyloidosis is a heart condition caused by the buildup of abnormal protein in the heart muscle that can lead to stiffening of the heart and congestive heart failure. Our Cardiac Amyloidosis Center provides multidisciplinary assessment and treatment for patients with suspected and confirmed cardiac amyloidosis. Our multidisciplinary team includes a cardio-oncologist, cardiac imagers, interventional cardiologists, hematologists and oncologists, a neurologist, a pathologist, a medical geneticist, and genetic counselors.
We perform blood and urine tests as well as heart imaging tests (ultrasound, nuclear scan, MRI) to accurately diagnose the type of amyloidosis. When the diagnosis is uncertain, our team includes interventional cardiologists with expertise in performing endomyocardial biopsy (obtaining a small piece of heart muscle) to confirm the diagnosis. Once a diagnosis is confirmed, a patient will work with our multidisciplinary team to determine the optimal treatment regimen and follow up plan.